Analyst Price Targets — RCEL
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| March 26, 2026 2:17 pm | — | Northland Securities | $10.00 | $3.86 | TheFly | Avita Medical stock pullback creates buying opportunity, says Northland |
| January 16, 2026 1:35 pm | — | Lake Street | $3.50 | $3.60 | TheFly | Avita Medical price target raised to $3.50 from $3 at Lake Street |
| October 17, 2025 11:38 am | Frank Takkinen | Lake Street | $4.00 | $5.38 | TheFly | Avita Medical downgraded to Hold from Buy at Lake Street |
| January 8, 2025 2:00 pm | Brooks O'Neil | Lake Street | $14.00 | $14.06 | TheFly | Avita Medical price target lowered to $14 from $20 at Lake Street |
| May 14, 2024 3:04 am | Matt O'Brien | Piper Sandler | $9.00 | $8.35 | StreetInsider | Piper Sandler Downgrades Avita Medical Ltd. (RCEL) to Neutral |
Latest News for RCEL
AVITA Medical, Inc. (RCEL) Shareholder/Analyst Call Transcript
Recognition highlights pioneering contributions to modern burn care including development of RECELL ® Spray-On Skin™ VALENCIA, Calif., April 15, 2026 (GLOBE NEWSWIRE) -- AVITA Medical®, Inc. (NASDAQ: RCEL, ASX: AVH), a leading therapeutic acute wound care company, today announced that its founder, Professor Fiona Wood, has been awarded the Lifetime Achievement Award by the American Burn Association (ABA).
Avita Medical (RCEL) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Cohealyx interim data show ~20-day reduction in time to graft vs benchmark, with strong investigator satisfaction and consistent performance across wounds.
LOS ANGELES, April 13, 2026 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises AVITA Medical, Inc. , (“ AVITA " or the "Company") ( NASDAQ : RCEL ) investors that the firm has initiated an investigation into possible securities fraud, and may file a class action on behalf of investors.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for RCEL.
U.S. House Trading
No House trades found for RCEL.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.